🟢 GT Biopharma is trading 10% up today after its 1-for-25 reverse split

GT Biopharma is trading at $5.78, up +10.02% on September 9, 2026, following its 1-for-25 reverse stock split, effective September 8.

• Nasdaq began split-adjusted trading at the September 8 market open with a new CUSIP.
• Shares outstanding fell from approximately 45.1 million to 1.8 million, creating substantial post-split trading volatility and explaining the sharp price adjustment.
• No additional major company-specific announcement was identified for September 9.